Objective:Xenical tablets are effective in the treatment of obesity and have demonstrated superior tolerability to weight loss compared with placebo. This study aimed to compare the safety of Xenical compared with placebo in obese patients with obesity.
Patients and methods:We conducted a multicenter, double-blind, randomized, placebo-controlled trial comparing the safety and tolerability of Xenical in obese patients with obesity to placebo. We included patients with a body mass index (BMI) ≥27 kg/m2 and ≥5 kg/m2 with a weight of ≥20 kg, defined as the lowest BMI at baseline, with at least one weight-related comorbidity, or with at least one weight-related comorbidity, and ≥5 kg/m2 or ≥5 kg/m2 with at least one weight-related comorbidity. Xenical was administered for an extended period of 3 months and patients were asked to take the medication for 12 weeks, at which time all patients could be randomly assigned to take the study medication, without the need to take the other medication. Patients were assessed for weight change and assessed for side effects. A validated, blinded-measurement, non-hierarchical, Xenical (QXENXEN) safety questionnaire was used to assess compliance with treatment. We also collected baseline and at least 12 weeks follow-up weight-related comorbidities. At baseline and follow-up, the primary end point was change in QXENXEN (QXENXEN) score at 12 weeks. Patients with a QXENXEN score ≥4 were also included in the study.
Results:The median age was 49 years and mean BMI was 28.5 kg/m2. The mean baseline QXENXEN score was 4.8, with the median QXENXEN score of 5.7, and the median number of weight-related comorbidities was 1.5. QXENXEN decreased by 4.1% and QXENXEN decreased by 1.2%. No difference in baseline QXENX score was seen between the placebo group and the Xenical group. At the 12-week follow-up, there were no differences in QXENX score between the Xenical and placebo groups at baseline, and after 12 weeks of treatment, the QXENXEN score improved in both groups. At 12 weeks, QXENXEN score did not improve significantly in the Xenical group.
Conclusions:QXENXEN (QXENXEN) was well tolerated in obese patients with obesity. The safety of QXENXEN was evaluated by a validated, blinded-measurement, non-hierarchical, Xenical (QXENXEN) safety questionnaire in obese patients with obesity. QXENXEN is an important tool in the assessment of patient compliance with weight-loss therapy.
IntroductionObesity is one of the leading causes of disability and disability-related health disorders worldwide. It is estimated that more than 50 million adults in the United States are estimated to be obese, with a lifetime prevalence of 5.1% [].Obesity is often associated with several health problems, including cardiovascular diseases, type 2 diabetes, hypertension, and dyslipidemia. The prevalence of obesity-related conditions in the United States is estimated to be about 2.7% (10.5%–13.2%) per million population. The prevalence of obesity-related conditions in the United States has been estimated to be about 10.5% (9.1%–16.6%) in adults aged ≥60 years. The United States currently has a population-based prevalence of 10.7% (7.0%–14.4%), which is higher than reported in other countries [].
The American Diabetes Association (ADA) recommends the use of lifestyle modifications to improve the prevalence of obesity in the United States. However, obesity is a chronic disease with an estimated prevalence of 3.7% (1.1%–7.8%) in the United States, which is considered to be the highest number of comorbidities in the United States []. The prevalence of obesity-related conditions in the United States is estimated to be between 5.5% and 12.6% [].
The World Health Organization (WHO) recommends the use of a combination of lifestyle interventions and dietary changes in patients with obesity to reduce the risk of metabolic diseases and the associated health problems []. Currently, there are no guidelines on the use of pharmacotherapy for weight loss in patients with obesity. Therefore, pharmacotherapy is the most important treatment approach for obesity in patients with obesity.
Xenical (orlistat) is an innovative weight loss medication that aids individuals in managing obesity by inhibiting the absorption of dietary fats in the intestine. Obesity is a significant health concern that increases the risk of various conditions, including heart disease, diabetes, and hypertension. Xenical offers a unique approach to weight management by preventing the breakdown and absorption of about 30% of the fat consumed in a meal, which is then excreted from the body. This reduction in fat absorption helps lower overall caloric intake, making it easier for individuals to lose weight and maintain a healthy lifestyle. When combined with a balanced diet and regular exercise, Xenical can significantly improve weight loss outcomes and reduce obesity-related health risks. It is a valuable tool for those struggling with weight management, providing support and efficacy in achieving long-term weight loss goals.
Benefits of Xenical:
Dosage:
Warnings and Precautions:
Usage Instructions:
Storage Information:
Common Side Effects:
Xenical, designed to assist those struggling with obesity, works by inhibiting the absorption of dietary fats in the intestine. This mechanism allows about 30% of the fat consumed in a meal, which is then excreted from the body, into the circulation. Xenical inhibits the absorption of about 30% of the fat consumed in a meal, ultimately reducing fat absorption by preventing the breakdown and absorption of about 30% of the fat consumed in a meal, which is then excreted from the body. This reduction in fat absorption helps lower overall caloric intake, which can significantly enhance weight loss.
A: Xenical is used to assist in weight loss by inhibiting the absorption of dietary fats. It works by preventing the breakdown and absorption of about 30% of the fat consumed in a meal, which is then excreted from the body.
Q: How should I use Xenical?
A: Xenical should be taken three times daily, with each main meal containing fat.
Q: Can I take Xenical with food?
A: No, Xenical should be taken with food. The recommended adult dose is one 120 mg capsule three times daily with each main meal containing fat.
Q: How does Xenical (orlistat) help weight loss?
A: Xenical helps individuals lose weight by preventing the breakdown of about 30% of the fat consumed in a meal, which is then excreted from the body. This reduction in fat absorption helps to lower overall caloric intake, which can significantly enhance weight loss.
If you’re new to weight loss treatments and want to learn more about them, we’re here to help.
Tablets like (the brand name for Orlistat) work by reducing the amount of fat your body absorbs. Ordinarily, fats are broken down during the digestion process by enzymes called lipases. Xenical prevents these enzymes from working effectively, limiting how much fat your body is able to absorb. The remaining, undigested fat is then excreted.
In contrast to Xenical, weight loss injections (or pens) work by suppressing your appetite - particularly your appetite for fatty foods. Some weight loss injections also slow the digestion process down, making you feel fuller for longer. They’re simple to use - check out our for more information.
Clinical trials have repeatedly demonstrated the effectiveness of both weight loss tablets and injections, particularly in combination with a healthy diet and lifestyle., participants using lost almost 15% of their body weight over a 15-month period.
Starting your weight loss journey is simple with IQ Doctor. To begin, click on a product and then hit the 'Start Consultation' button. The online consultation process is quick, simple and free; just complete the form and we’ll verify whether the medication is suitable for you or not. If it is, you can then place your order and receive it the very next day.
Add your statementThank you for donated your medication
New medication statementNew medication statement new medication statement new medication statement
Your medicationYour medication(s) are medically identical to those on our site. You can have or share your medication with our doctors. We offer no liability for any medical error made by using or reliance on our site.
Your medication is a result of your visit to our website. Continue to visit our site and you’ll see which weight loss medication is most effective for you. If you complete your visit we will send you a medicine directly to your door. In few months, you’ll be able to start using our site and your medication will be on our top priority list.
Your medication(s) are medically identical to our site. You can have or share your medication with or share your medication with us. We offer no liability for medical error made by using or reliance on our site.
Orlistat is a lipase inhibitor. It belongs to a class of drugs called lipase inhibitors. It works by preventing the fat from your stomach and small intestines from your meal by attaching to these enzymes and preventing the body from breaking down of fat in these areas. This leads to decreased hormones responsible for keeping stomach emptying. By lowering calorie intake, orlistat helps to decrease the amount of fat your body absorbs.
As a safe drug, you should not use Orlistat if you are past your 60s. Our experienced pharmacists are available to help you determine if Orlistat is appropriate for you. However, it’s important to do so from a medical perspective. Our commitment is to help you achieve your weight loss goals, so complete our free online consultation process to ensure the best outcome for you.
Our weight loss injections include:
We encourage your medication to be a convenient, daily low-fat diet that’s low in sugar, fibre and alcohol. Your medication may be given along with a orlistat daily to help you reduce your calorie intake.
The orlistat or diet is a low-fat diet. Your medication should be part of the orlistat-sized daily low-fat diet. Your medication should be part of the low-fat orlistat-sized daily diet. The orlistat or diet is part of the diet.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Healthylife Product Information/TrademARK Healthylife Product Information/Drugs APPLICation Directions Directions Strength 120 capsules/4 times daily for 7 days or as directed by your GP or a pharmacist. Maximum 2 capsules per day.Healthylife. Product ID: 523(R) Pharmacy Code: FA6YHSA08
Product information requires a script. Always read the label. The information provided here is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used as a substitute for advice from a doctor. Always consult your healthcare provider for specific advice regarding your health. If you have any questions or concerns, please talk to your healthcare provider.
Product packaging: Spcipher: BVX2DUJF
Pharmacy support: 844/825-039
Pharmacy information: BVX2DUJF
Storage: Store out of children's reach. Do not store in the bathroom,escalation, or space below 25°C. Store out of reach of children and pets.
Product information: FA6YSA08
Product information: BVX2DUJF
Stade de France Pharmacy